T

TransMedics Group
D

TMDX

136.170
USD
-5.88
(-4.14%)
مغلق
حجم التداول
0
الربح لكل سهم
2
العائد الربحي
-
P/E
96
حجم السوق
4,607,146,912
أصول ذات صلة
ABT
ABT
-1.740
(-1.30%)
132.260 USD
ALGN
ALGN
-7.490
(-4.10%)
175.090 USD
BAX
BAX
-0.880
(-2.86%)
29.930 USD
BDX
BDX
-2.180
(-1.27%)
169.970 USD
DHR
DHR
-5.360
(-2.66%)
195.780 USD
EW
EW
-1.530
(-2.05%)
73.280 USD
HOLX
HOLX
-1.050
(-1.61%)
64.150 USD
IDXX
IDXX
-8.27
(-1.56%)
520.51 USD
ISRG
ISRG
-7.05
(-1.36%)
511.91 USD
TMO
TMO
-14.95
(-3.69%)
390.27 USD
ZBH
ZBH
-1.960
(-2.13%)
90.220 USD
المزيد
الأخبار المقالات

العنوان: TransMedics Group

القطاع: Healthcare
الصناعة: Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.